Ragon Institute of Mass General, MIT, and Harvard
Daniela Russo is currently pursuing a PhD in Immunology at Harvard Medical School since August 2024, while also serving as a Bioinformatics Analyst II at the Ragon Institute of MGH, MIT, and Harvard since April 2021, where bioinformatic approaches are applied to study regeneration mechanisms in Hydra. Prior experience includes working as a Laboratory Research Assistant at McMaster University from September 2018 to February 2021 and serving as an Undergraduate Teaching Assistant for various Life Sciences courses. Daniela also held roles as VP Management at Smart Steps McMaster, Research Assistant at St. Joseph's Healthcare Hamilton, and Peer Mentor for McMaster University International Student Services, in addition to previous positions as an Appointment Call Center Agent at REMAX Escarpment, Sales Associate at DSW, and Sales Office Administrator at Tribute Communities. Daniela earned a Bachelor of Science in Life Sciences from McMaster University in June 2020.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.